WHO panel gives nod to AstraZeneca COVID-19 vaccine, has 'tremendous potential'
WorldFILE PHOTO: The logo of the World Health Organization (WHO), is seen before a news conference in Geneva, Switzerland, June 25, 2020. REUTERS/Denis Balibouse20 Mar 2021 12:30AMShare this contentBookmarkGENEVA: The World Health Organization's vaccine safety panel said on Friday (Mar 19) that data from AstraZeneca's COVID-19 shot do not point to any overall increase in clotting conditions but it would continue to monitor its effects.
"The AstraZeneca COVID-19 vaccine (including Covishield) continues to have a positive benefit-risk profile, with tremendous potential to prevent infections and reduce deaths across the world," the WHO's global advisory committee on vaccine safety said in a statement issued after its independent experts met on Tuesday and on Thursday to review data.Read more: CNA »
S'pore-HK air travel bubble starts May 26, 2 daily flights capped at 200 passengers each for first 2 weeks
Definitely has tremendous potential ..hahaha